Research Topics
| M C HosseinipourSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, MalawiRalf Weigel
Lighthouse Trust at Kamuzu Central Hospital and Ministry of Health, Lilongwe, Malawi
BMC Infect Dis 11:31. 2011....- Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baselineM C Hosseinipour
University of North Carolina Project, Lilongwe, Malawi
HIV Med 11:510-8. 2010..Advanced disease progression may occur before switching to second-line ART. We report outcomes for patients evaluated and initiated on second-line treatment in Malawi... - The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapyMina C Hosseinipour
University of North Carolina Project, Lilongwe, Malawi
AIDS 23:1127-34. 2009..We evaluated drug resistance patterns among patients failing first-line ART on the basis of clinical or immunological criteria in Lilongwe and Blantyre, Malawi... - HIV and parasitic infection and the effect of treatment among adult outpatients in MalawiMina C Hosseinipour
University of North Carolina Project, Lilongwe, Malawi
J Infect Dis 195:1278-82. 2007..Successful treatment of parasitic infections had no effect on HIV RNA levels. Although common, parasitic infections did not impact HIV RNA levels... - Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resourcesMina C Hosseinipour
University of North Carolina Project, Kamuzu Central Hospital, 100 Mzimba Road, Private Bag A 104, Lilongwe, Malawi
Curr HIV/AIDS Rep 7:168-74. 2010..We review currently available evidence related to monitoring strategies in RLS and discuss their implications on timing of switching to second-line treatment, development of HIV resistance, and clinical outcome... - The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian womenIrving F Hoffman
Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC 27599, USA
J Acquir Immune Defic Syndr 47:477-83. 2008.... - Maternal or infant antiretroviral drugs to reduce HIV-1 transmissionCharles S Chasela
University of North Carolina Project, Lilongwe, Malawi
N Engl J Med 362:2271-81. 2010..We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus type 1 (HIV-1) in Malawi... - Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007Lillian B Brown
Division of Infectious Diseases, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
Sex Transm Dis 37:169-72. 2010..We sought to establish current laboratory-based Neisseria gonorrhoeae antibiotic susceptibility patterns for Malawi and describe the pattern of susceptibility since syndromic management began... - Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian childrenAmanda H Corbett
University of North Carolina Schools of Pharmacy, Medicine and Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Antivir Ther 15:83-90. 2010.... - Management of cryptococcal meningitis in sub-saharan AfricaArthur Jackson
University of North Carolina Project, Kamuzu Central Hospital, 100 Mzimba Road, Private Bag A 104, Lilongwe, Malawi
Curr HIV/AIDS Rep 7:134-42. 2010..Emphasis has been given to recent articles and landmark trials, and opinion is given from the authors' own experiences... - Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experienceMina C Hosseinipour
University of North Carolina Project, Lilongwe, Malawi
J Int Assoc Physicians AIDS Care (Chic Ill) 5:103-8. 2006..Severe toxicity rate was low. Areas for improved program performance include lower cost, wide and earlier access to antiretroviral therapy, and targeted retention strategies... - Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiJesse C Nussbaum
University of North Carolina UNC Project and 2Kamuzu Central Hospital, Lilongwe, Malawi
Clin Infect Dis 50:338-44. 2010..Fluconazole at a dosage of 1200 mg per day is more fungicidal than at a dosage of 800 mg per day, but mortality rates remain unacceptably high. Therefore, we examined the effect of adding oral flucytosine to fluconazole... - Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adultsMina C Hosseinipour
University of North Carolina Project, Lilongwe Malawi
AIDS 21:59-64. 2007..The Malawian antiretroviral program uses generic Triomune (stavudine, lamivudine, and nevirapine)... - Challenges in delivering antiretroviral treatment in resource poor countriesMina C Hosseinipour
School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA
AIDS 16:S177-87. 2002